What is Mitsubishi Tanabe Pharma's environmental accountability evil score?

Mitsubishi Tanabe Pharma has an ESG accountability Evil Score of 64/100, indicating severe levels of non-compliance, heavy carbon intensity, or active environmental litigation opposition.

How much carbon emissions does Mitsubishi Tanabe Pharma produce?

Mitsubishi Tanabe Pharma produces direct Scope 1 & Scope 2 greenhouse emissions totaling 103 Megatonnes of CO2 equivalent annually, as tracked on our persistent audit framework.

Has Mitsubishi Tanabe Pharma been audited for deforestation or litigation fines?

Yes, our real-time audit tracks 307 hectares of satellite-detected deforestation, with compiled historical litigation fines totaling $1,262,288,892 USD. See full investigation details.

← RETURN TO CORPORATE INDEX

Pharmaceuticals • Asia

Mitsubishi Tanabe Pharma

HEADQUARTERS: Germany Strategic Hub • FOUNDED: 1881

DESTRUCTION SCORE 64/100

Corporative Audit Overview

A dominant force in the Pharmaceuticals sector, Mitsubishi Tanabe Pharma maintains a complex global operation spanning Asia. Recent environmental audits highlight significant ecological challenges resulting from their industrial output and resource extraction methods.

Carbon tracked (CO2) 103 Mt 70 Mt Scope 1/2

Deforestation Index 307 HA Primary forest cleared

Litigated Infractions 1332 Incidents $1262.3M Paid Fines

Climate Lobbying $769.2M Emission opposition focused

Timeline of Global Infractions & Audits

2023 Greenwashing Financial Bonds

Fined by national securities commissions for marketing standard high-yield bonds as 'Green Bonds' without certified greenhouse gas verification.

2024 Data Center Coal Grid Contract

Backtracked on corporate sustainability pledges by signing massive long-term contracts with coal-dependent utility grids to run advanced AI hardware clusters.

Live Sensor Logging Watch

ANOMALY Grid Energy Surge Detect

Third-party grid monitors recorded a sudden 28% energy load spike from un-audited coal-heavy grid zones supporting Mitsubishi Tanabe Pharma's servers in Germany.

2024-05-12

ENFORCEMENT Greenwash Deception Fine

Mexico regulatory authority ordered a $8.1M USD penalty for deceptive marketing of corporate sustainability targets.

2024-03-28

DATA_SYNC Scope 3 Intensity Sync

Value chain Scope 3 indirect logistics metrics updated. Intensity increased by 4.3% due to carbon-heavy transport partners.

2024-01-15

PROBE Supply Chain Mineral Audit

Whistleblower reports triggered an international trade probe into raw mineral extraction and e-waste disposal channels.

2023-11-20

Executive Directors

Linda Davis

Chief Executive

James Martinez

Head of ESG Strategy

Sub-brands & Subsidiaries

Mitsubishi Tanabe Pharma Pharmaceuticals Dynamics Global Resource Systems Bio-Tech Logistics